Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Eli Lilly and Company
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Have a body weight not exceeding 150 kilograms (kg) or 330 pounds (lb) and body mass index (BMI) within the range of 30 to 40 kilogram per square meter (kg/m²)
Have had a stable body weight that is less than or equal to 5% change in body weight for 3 months prior to screening and enrollment
You may not be if
Have a lifetime history of a suicide attempt
Have a history or presence of psychiatric disorders, including a history of major depressive disorder within the last 2 years
Have a baseline Patient Health Questionnaire-9 (PHQ-9) score of 15 or greater, and/or a score of 2 or greater for either of the first 2 questions on the PHQ-9 questionnaire
Have a known clinically significant gastric emptying abnormality, have undergone gastric bypass surgery or restrictive bariatric surgery
Have taken approved or investigational medication for weight loss, within the previous 3 months or 5 half-lives of study screening, whichever is earlier
Intend to use any weight-loss medications during study participation
Have obesity induced by other endocrinologic disorders or diagnosed monogenetic or syndromic forms of obesity
Clareo Health | A Study of LY3532226 in Participants With Obesity
